ARTICLE | Clinical News
AAV2-GDNF: Phase I started
September 2, 2013 7:00 AM UTC
uniQure said researchers at the University of California, San Francisco and the NIH's National Institute of Neurological Disorders and Stroke (NINDS) began an open-label, dose-escalation Phase I tria...